The Relation Between Hypertension and Angiotensin Converting Enzyme Genotype in Iraqi. | [Pakistan Journal of Biotechnology • 2018]

Author(s):

1. Israa Adnan Ibraheam: College of science for Women, University of Babylon, Babil, Iraq

2. Tsahel Hamed Al-dulaimi: College of science for Women, University of Babylon, Babil, Iraq

3. Sabreen Kamal Abd alameer: College of science for Women, University of Babylon, Babil, Iraq

4. Zainab Khudhur Ahmad Al-Mahdi: College of Dentistry, University of Babylon

5. Hawraa Wahab Aziz: College of science for Women, University of Babylon, Babil, Iraq

6. Amal Raqib Shimran: College of science for Women, University of Babylon, Babil, Iraq

Abstract:

The source of most common chronic condition attributed to high blood pressure or hypertension, which affect about 20%-30% of the adult males and female's population. The present study is aimed to determine the association, of angiotensin converting enzyme genotype with Iraqis' hypertensive patients. The study was carried out on 30 Iraqi patients having hypertension and 30 healthy subjects as control. Blood samples were collected from both patients and the healthy subjects, DNA from the patients and control specimens were isolated, Detecting of ACE insertion deletion genotype was done by polymerase chain reaction. The results show association between ACE genotype with hypertension DD genotype was increase in patients than control. The present study reported the relation between angiotensin converting enzyme genotype among Iraqis' hypertensive patients.

Page(s): 15-17

DOI: DOI not available

Published: Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 1, Year: 2018

Keywords:

Keywords are not available for this article.

References:

[1] Arnett D.K ., B.R.,Davis , C.E.,Ford,,2005,Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymerphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) study,Circulation,111,3374-3383

[2] Borlay , A.J.,Suharsono,,2017,Development of single nucleotide polymorphisms (SNPS) marker for oleic acid content in oil palm (Elaeis guineensis Jacq,Pak. J. Biotechnol,14,55-62

[3] Carretero O.A . and S.,Oparil,,2000,Essential hypertension. Part I: Definition and etiology,Circulation,101,329-335

[4] Chung C.M.,R.Y.Wang,J.W.Chen,,2010,A genome-wide association study identifies new loci for ACE activity: Potential implications for response to ACE inhibitor,Pharmacoge-nomics,10,537-544

[5] Deepika , N.L.N.,K.R.Reddy,M.Balakrishna,K.P.PrasannaLatha and J. Parveen,,2013,Do ACE I/D gene polymorphism serve as a predictive marker for age at,PCOS? J. Assist. Reprod. Genet,30,125-130

[6] Ehret G.B.,,2010,Genome-wide association studies: Contribution of genomics to understanding blood pressure and essential hypertension,Curr. Hypertens. Rep,12,17-25

[7] Fayyad , H.A.D.,I.H.Aziz,,2015,Genetic polymerphism of angiotensingen gene in high blood pressure,World Journalof Pharmacy and Pharmaceutical Sciences,4,1910-1917

[8] William J. He , Changwei,Li , Dabeeru C.,Rao,,2015,Shimmin, Dong-feng Gu and Tanika N. Kelly, Associations of Renin Angiotensin Aldosterone System Genes with Blood Pressure Changes and Hypertens-ion Incidence,American Journal of Hyper-tension,28,1310-1315

[9] Hermida R.C. , D.E.,Ayala , R.,Fernández,,2011,Circadian rhythms in blood pressure regulat-ion and optimization of hypertension treatm-ent with ACE inhibitor and ARB medications,Am J Hypertens,24,383-391

[10] Higaki J. , S.,Baba , T.,Katsuya , N.,Sato , K.,Ishikawa , T.,Mannami , J.,Ogata and T.,Ogihara,,2000,Deletion allele of angiotensin-con-verting enzyme gene increases risk of essen-tial hypertension in Japanese men: the Suita Study,Circulation,101,2060-2065

[11] Miller J.A.,J.W.Scholey,,2004,The impact of reninangiotensin system polymorphisms on physiological and pathophysiological processes in humans,Curr. Opin. Nephrol. Hypertens,13,101-106

[12] KonoshitaT.,,2011,Do genetic variants of the reninangiotensin system predict blood pressure response to renin-angiotensin system-blocking drugs? A systematic review of pharmacogenomics in the renin-angiotensin system,Curr. Hypertens Rep,13,356-361

[13] RigatB.,C. Hubert , F.,Alhenc-Gelas , F.,Cambien , P.,Corvol and F.,Soubrier,,1990,An insertion/ delet- ion polymorphism in the angiotensin I-conv-erting enzyme gene accounting for half the variance of serum enzyme levels,J. Clin. Invest,86,1343-1346

[14] RukavinaMikusic,N.L.,N.M.Kouyoumdzian,,2018,Effects of chronic fructose overload on renal dopaminergic system: alteration of urin- ary Ldopa/dopamine index correlates to hypertension and precedes kidney structural damage,Journal of Nutritional Biochemistry,51,47-55

[15] Schelleman H. , O.H.,Klungel,C.M. Van,,2006,Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy,,40,212-218

[16] Schelleman H. , O.H.,Klungel,C.M. van Duijn,,2005,Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors,Br. J. ClinPharmacol,59,483-485

[17] TaverneK.,M. de Groot,,2010,Gene-tic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs,Expert Opin. Drug Metab. Toxicol,6,439-460

[18] ThielB.,A.B. Weder,,2000,,J. Clin. Hypertens,2,187-193

[19] TsukadaK.,T.Ishimitsu,N.Tsuchiya,S , Hori-naka and H. Matsuoka,,1997,Angiotensin-conver-ting enzyme gene polymorphism and cardio-vascular endocrine system in coronary angio-graphy patients,Jpn Heart J,38,799-810

[20] Yu H.,Y.Zhang,,2003,Relationship betw-een polymorphism of the angiotensin-conve-rting enzyme gene and the response to angio-tensinconverting enzyme inhibition in hyper-tensive patients,Hypertens. Res,26,881-886

[21] ZhuX.,Y.P.Chang,D.Yan,,2003,Associations between hypertension and genes in the reninangiotensin system,Hypertension,41,1027-1034

Citations

Downloads

Views